Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

1.

Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.

Bertwistle D, Sherr CJ.

Blood. 2007 Jan 15;109(2):792-4. Epub 2006 Sep 12.

PMID:
16968893
[PubMed - indexed for MEDLINE]
Free Article
2.

Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.

Eischen CM, Alt JR, Wang P.

Oncogene. 2004 Nov 25;23(55):8931-40.

PMID:
15467748
[PubMed - indexed for MEDLINE]
3.

Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.

Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL.

Mol Cell Biol. 2001 Nov;21(22):7653-62.

PMID:
11604501
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.

Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF, Cleveland JL.

Mol Cell. 2003 Apr;11(4):905-14.

PMID:
12718877
[PubMed - indexed for MEDLINE]
5.

p19ARF directly and differentially controls the functions of c-Myc independently of p53.

Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR.

Nature. 2004 Oct 7;431(7009):712-7. Epub 2004 Sep 8.

PMID:
15361884
[PubMed - indexed for MEDLINE]
6.

Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.

Nilsson LM, Keller UB, Yang C, Nilsson JA, Cleveland JL, Roussel MF.

Oncogene. 2007 May 3;26(20):2833-9. Epub 2006 Nov 13.

PMID:
17099725
[PubMed - indexed for MEDLINE]
7.

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL.

Genes Dev. 1999 Oct 15;13(20):2658-69.

PMID:
10541552
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.

Shreeram S, Hee WK, Demidov ON, Kek C, Yamaguchi H, Fornace AJ Jr, Anderson CW, Appella E, Bulavin DV.

J Exp Med. 2006 Dec 25;203(13):2793-9. Epub 2006 Dec 11.

PMID:
17158963
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.

Baxter EW, Blyth K, Cameron ER, Neil JC.

J Virol. 2001 Oct;75(20):9790-8.

PMID:
11559812
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

p53 and p73 in suppression of Myc-driven lymphomagenesis.

Griesmann H, Schlereth K, Krause M, Samans B, Stiewe T.

Int J Cancer. 2009 Jan 15;124(2):502-6. doi: 10.1002/ijc.23978.

PMID:
18942718
[PubMed - indexed for MEDLINE]
11.

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.

Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL.

Cancer Cell. 2005 May;7(5):433-44.

PMID:
15894264
[PubMed - indexed for MEDLINE]
Free Article
12.

Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.

Datta A, Nag A, Pan W, Hay N, Gartel AL, Colamonici O, Mori Y, Raychaudhuri P.

J Biol Chem. 2004 Aug 27;279(35):36698-707. Epub 2004 Jun 15.

PMID:
15199070
[PubMed - indexed for MEDLINE]
Free Article
13.

Bim is a suppressor of Myc-induced mouse B cell leukemia.

Egle A, Harris AW, Bouillet P, Cory S.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6164-9. Epub 2004 Apr 12.

PMID:
15079075
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.

Wang J, Boxer LM.

J Biol Chem. 2005 Apr 1;280(13):12766-73. Epub 2005 Feb 1.

PMID:
15687498
[PubMed - indexed for MEDLINE]
Free Article
15.

The ARF tumor suppressor: keeping Myc on a leash.

Gregory MA, Qi Y, Hann SR.

Cell Cycle. 2005 Feb;4(2):249-52. Epub 2005 Feb 21.

PMID:
15655352
[PubMed - indexed for MEDLINE]
Free Article
16.

Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathway.

Nagao M, Campbell K, Burns K, Kuan CY, Trumpp A, Nakafuku M.

J Cell Biol. 2008 Dec 29;183(7):1243-57. doi: 10.1083/jcb.200807130.

PMID:
19114593
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

MIF loss impairs Myc-induced lymphomagenesis.

Talos F, Mena P, Fingerle-Rowson G, Moll U, Petrenko O.

Cell Death Differ. 2005 Oct;12(10):1319-28.

PMID:
15947793
[PubMed - indexed for MEDLINE]
Free Article
19.

Tumor spectrum in ARF-deficient mice.

Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ.

Cancer Res. 1999 May 1;59(9):2217-22.

PMID:
10232611
[PubMed - indexed for MEDLINE]
Free Article
20.

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.

Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW.

Nature. 2005 Aug 11;436(7052):807-11.

PMID:
16094360
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk